T1	Pharmacodynamic_phenotype	30 50	response to Icotinib
T2	Pharmacodynamic_phenotype	59 69	crizotinib
T3	Limited_variation	92 109	EGFR mutation was
T4	Gene_or_protein	135 150	ROS1 fusion and
T5	Limited_variation	151 168	KRAS mutation not
R1	isAssociatedWith	Arg1:T1	Arg2:T5
R2	influences	Arg1:T2	Arg2:T1
R3	influences	Arg1:T2	Arg2:T3
R4	influences	Arg1:T2	Arg2:T4
R5	influences	Arg1:T2	Arg2:T5
R6	influences	Arg1:T3	Arg2:T1
R7	influences	Arg1:T3	Arg2:T2
R8	influences	Arg1:T3	Arg2:T4
R9	influences	Arg1:T3	Arg2:T5
R10	influences	Arg1:T4	Arg2:T1
R11	influences	Arg1:T4	Arg2:T2
R12	influences	Arg1:T4	Arg2:T3
R13	influences	Arg1:T4	Arg2:T5
R14	influences	Arg1:T5	Arg2:T1
R15	influences	Arg1:T5	Arg2:T2
R16	isAssociatedWith	Arg1:T5	Arg2:T3
R17	isAssociatedWith	Arg1:T5	Arg2:T4
